Cargando…

Therapeutic effects and safety of oral Chinese patent medicine for COVID-19: A rapid systematic review and meta-analysis of randomized controlled trials

Detalles Bibliográficos
Autores principales: Liang, Shi-Bing, Zhang, Ying-Ying, Fang, Min, Liang, Chang-Hao, Lan, Hui-Di, Shen, Chen, Yan, Li-Jiao, Hu, Xiao-Yang, Han, Mei, Robinson, Nicola, Liu, Jian-Ping
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Published by Elsevier GmbH 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8696019/
http://dx.doi.org/10.1016/j.eujim.2021.101979
_version_ 1784619712039092224
author Liang, Shi-Bing
Zhang, Ying-Ying
Fang, Min
Liang, Chang-Hao
Lan, Hui-Di
Shen, Chen
Yan, Li-Jiao
Hu, Xiao-Yang
Han, Mei
Robinson, Nicola
Liu, Jian-Ping
author_facet Liang, Shi-Bing
Zhang, Ying-Ying
Fang, Min
Liang, Chang-Hao
Lan, Hui-Di
Shen, Chen
Yan, Li-Jiao
Hu, Xiao-Yang
Han, Mei
Robinson, Nicola
Liu, Jian-Ping
author_sort Liang, Shi-Bing
collection PubMed
description
format Online
Article
Text
id pubmed-8696019
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Published by Elsevier GmbH
record_format MEDLINE/PubMed
spelling pubmed-86960192021-12-23 Therapeutic effects and safety of oral Chinese patent medicine for COVID-19: A rapid systematic review and meta-analysis of randomized controlled trials Liang, Shi-Bing Zhang, Ying-Ying Fang, Min Liang, Chang-Hao Lan, Hui-Di Shen, Chen Yan, Li-Jiao Hu, Xiao-Yang Han, Mei Robinson, Nicola Liu, Jian-Ping Eur J Integr Med Article Published by Elsevier GmbH 2021-12 2021-12-17 /pmc/articles/PMC8696019/ http://dx.doi.org/10.1016/j.eujim.2021.101979 Text en Copyright © 2021 Published by Elsevier GmbH. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active.
spellingShingle Article
Liang, Shi-Bing
Zhang, Ying-Ying
Fang, Min
Liang, Chang-Hao
Lan, Hui-Di
Shen, Chen
Yan, Li-Jiao
Hu, Xiao-Yang
Han, Mei
Robinson, Nicola
Liu, Jian-Ping
Therapeutic effects and safety of oral Chinese patent medicine for COVID-19: A rapid systematic review and meta-analysis of randomized controlled trials
title Therapeutic effects and safety of oral Chinese patent medicine for COVID-19: A rapid systematic review and meta-analysis of randomized controlled trials
title_full Therapeutic effects and safety of oral Chinese patent medicine for COVID-19: A rapid systematic review and meta-analysis of randomized controlled trials
title_fullStr Therapeutic effects and safety of oral Chinese patent medicine for COVID-19: A rapid systematic review and meta-analysis of randomized controlled trials
title_full_unstemmed Therapeutic effects and safety of oral Chinese patent medicine for COVID-19: A rapid systematic review and meta-analysis of randomized controlled trials
title_short Therapeutic effects and safety of oral Chinese patent medicine for COVID-19: A rapid systematic review and meta-analysis of randomized controlled trials
title_sort therapeutic effects and safety of oral chinese patent medicine for covid-19: a rapid systematic review and meta-analysis of randomized controlled trials
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8696019/
http://dx.doi.org/10.1016/j.eujim.2021.101979
work_keys_str_mv AT liangshibing therapeuticeffectsandsafetyoforalchinesepatentmedicineforcovid19arapidsystematicreviewandmetaanalysisofrandomizedcontrolledtrials
AT zhangyingying therapeuticeffectsandsafetyoforalchinesepatentmedicineforcovid19arapidsystematicreviewandmetaanalysisofrandomizedcontrolledtrials
AT fangmin therapeuticeffectsandsafetyoforalchinesepatentmedicineforcovid19arapidsystematicreviewandmetaanalysisofrandomizedcontrolledtrials
AT liangchanghao therapeuticeffectsandsafetyoforalchinesepatentmedicineforcovid19arapidsystematicreviewandmetaanalysisofrandomizedcontrolledtrials
AT lanhuidi therapeuticeffectsandsafetyoforalchinesepatentmedicineforcovid19arapidsystematicreviewandmetaanalysisofrandomizedcontrolledtrials
AT shenchen therapeuticeffectsandsafetyoforalchinesepatentmedicineforcovid19arapidsystematicreviewandmetaanalysisofrandomizedcontrolledtrials
AT yanlijiao therapeuticeffectsandsafetyoforalchinesepatentmedicineforcovid19arapidsystematicreviewandmetaanalysisofrandomizedcontrolledtrials
AT huxiaoyang therapeuticeffectsandsafetyoforalchinesepatentmedicineforcovid19arapidsystematicreviewandmetaanalysisofrandomizedcontrolledtrials
AT hanmei therapeuticeffectsandsafetyoforalchinesepatentmedicineforcovid19arapidsystematicreviewandmetaanalysisofrandomizedcontrolledtrials
AT robinsonnicola therapeuticeffectsandsafetyoforalchinesepatentmedicineforcovid19arapidsystematicreviewandmetaanalysisofrandomizedcontrolledtrials
AT liujianping therapeuticeffectsandsafetyoforalchinesepatentmedicineforcovid19arapidsystematicreviewandmetaanalysisofrandomizedcontrolledtrials